CCI vs NRIX · P/E 40, rev $6.57B vs rev $54.5M
Crown Castle (CCI) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CCI and NRIX stock pages for the full models.
Not investment advice.